Effects of Arzoxifene on Bone Mass and the Uterus

NCT00085956 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Postmenopausal Bone Loss

Interventions

DRUG: Arzoxifene
DRUG: Placebo

Sponsor

Eli Lilly and Company